Fluid intake and risk of bladder cancer in the Nurses' Health Studies

International Journal of Cancer

Volumn 135, Issue 5, 2014, Pages 1229-1237

  Zhou, Jiachen ^a,b   Kelsey, Karl T ^a,c   Giovannucci, Edward ^d,e   Michaud, Dominique S ^a,f  

^a BROWN UNIVERSITY   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c BROWN UNIVERSITY   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

^f IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

bladder cancer; cohort study; fluid intake; smoking; water; women

Indexed keywords

ADULT; ARTICLE; BEVERAGE; BLADDER CANCER; CANCER RISK; COHORT ANALYSIS; DISEASE ASSOCIATION; FEMALE; FLUID INTAKE; FOOD FREQUENCY QUESTIONNAIRE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; REGISTERED NURSE; RISK REDUCTION; SMOKING;

BLADDER CANCER; COHORT STUDY; FLUID INTAKE; SMOKING; WATER; WOMEN;

DRINKING; DRINKING BEHAVIOR; FEMALE; FOOD HABITS; HUMANS; MIDDLE AGED; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK; RISK ASSESSMENT; RISK FACTORS; SMOKING; URINARY BLADDER NEOPLASMS; URINATION;

EID: 84902544491     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28764     Document Type: Article

References (43)

1. McDonald D, Lund RR,. The role of the urine in vesical neoplasm. I. Experimental confirmation of the urogenous theory of pathogenesis. J Urol 1954; 71: 560-570.
2. Oyasu R, Hopp ML,. The etiology of cancer of the bladder. Surg Gynecol Obstet 1974; 138: 97-108.
3. Silverman DT, Hartge P, Morrison AS, et al. Epidemiology of bladder cancer. Hematol Oncol Clin North Am 1992; 6: 1-30.
4. Komulainen H,. Experimental cancer studies of chlorinated by-products. Toxicology 2004; 198: 239-248.
5. Michaud DS, Kogevinas M, Cantor KP, et al. Total fluid and water consumption and the joint effect of exposure to disinfection by-products on risk of bladder cancer. Environ Health Perspect 2007; 115: 1569-1572.
6. Villanueva CM, Cantor KP, Grimalt JO, et al. Bladder cancer and exposure to water disinfection by-products through ingestion, bathing, showering, and swimming in pools. Am J Epidemiol 2007; 165: 148-156.
7. Villanueva CM, Cantor KP, King WD, et al. Total and specific fluid consumption as determinants of bladder cancer risk. Int J Cancer 2006; 118: 2040-2047.
8. Letasiova S, Medve'ova A, Sovcikova A, et al. Bladder cancer, a review of the environmental risk factors. Environ Health 2012; 11 Suppl 1: S11.
9. Morales KH, Ryan L, Kuo TL, et al. Risk of internal cancers from arsenic in drinking water. Environ Health Perspect 2000; 108: 655-661.
10. Volanis D, Kadiyska T, Galanis A, et al. Environmental factors and genetic susceptibility promote urinary bladder cancer. Toxicol Lett 2010; 193: 131-137.
11. Schuhmacher-Wolz U, Dieter HH, Klein D, et al. Oral exposure to inorganic arsenic: evaluation of its carcinogenic and non-carcinogenic effects. Crit Rev Toxicol 2009; 39: 271-298.
12. Silverman DT DS, Moore LE, Rothman N,. Bladder cancer. In:, Schottenfeld D, Fraumeni JF Jr, eds. Cancer epidemiology and prevention. New York: Oxford University Press; 2006. 1101-1127.
13. Silberstein JL, Parsons JK,. Evidence-based principles of bladder cancer and diet. Urology 2010; 75: 340-346.
14. Mills PK, Beeson WL, Phillips RL, et al. Bladder cancer in a low risk population: results from the Adventist Health Study. Am J Epidemiol 1991; 133: 230-239.
15. Michaud DS, Spiegelman D, Clinton SK, et al. Fluid intake and the risk of bladder cancer in men. N Engl J Med 1999; 340: 1390-1397.
16. Zeegers MP, Dorant E, Goldbohm RA, et al. Are coffee, tea, and total fluid consumption associated with bladder cancer risk? Results from the Netherlands Cohort Study. Cancer Causes Control 2001; 12: 231-238.
17. Ros MM, Bas Bueno-de-Mesquita HB, Buchner FL, et al. Fluid intake and the risk of urothelial cell carcinomas in the European Prospective Investigation into Cancer and Nutrition (EPIC). Int J Cancer 2011; 128: 2695-2708.
18. Zhou J, Smith S, Giovannucci E, et al. Reexamination of total fluid intake and bladder cancer in the Health Professionals Follow-up Study Cohort. Am J Epidemiol 2012; 175: 696-705.
19. American Cancer Society. Cancer facts and figures 2012. Atlanta: American Cancer Society, 2012.
20. Belanger CF, Hennekens CH, Rosner B, et al. The nurses' health study. Am J Nurs 1978; 78: 1039-1040.
21. Colditz GA, Manson JE, Hankinson SE,. The Nurses' Health Study: 20-year contribution to the understanding of health among women. J Womens Health 1997; 6: 49-62.
22. Nelson NJ,. Nurses' health study: nurses helping science and themselves. J Natl Cancer Inst 2000; 92: 597-599.
23. Stampfer MJ, Willett WC, Speizer FE, et al. Test of the national death index. Am J Epidemiol 1984; 119: 837-839.
24. Rich-Edwards JW, Corsano KA, Stampfer MJ,. Test of the National Death Index and Equifax Nationwide Death Search. Am J Epidemiol 1994; 140: 1016-1019.
25. Willett WC, Sampson L, Stampfer MJ, et al. Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol 1985; 122: 51-65.
26. Salvini S, Hunter DJ, Sampson L, et al. Food-based validation of a dietary questionnaire: the effects of week-to-week variation in food consumption. Int J Epidemiol 1989; 18: 858-867.
27. Feskanich D, Rimm EB, Giovannucci EL, et al. Reproducibility and validity of food intake measurements from a semiquantitative food frequency questionnaire. J Am Diet Assoc 1993; 93: 790-796.
28. Hu FB, Stampfer MJ, Rimm E, et al. Dietary fat and coronary heart disease: a comparison of approaches for adjusting for total energy intake and modeling repeated dietary measurements. Am J Epidemiol 1999; 149: 531-540.
29. Willett WC,. Nutritional epidemiology, 2nd edn., Chapter 6. Reproducibility and validity of food-frequency questionnaires. New York: Oxford University Press, 1998.
30. Anastasiadis A, de Reijke TM,. Best practice in the treatment of nonmuscle invasive bladder cancer. Ther Adv Urol 2012; 4: 13-32.
31. Dorkin TJ, Robson CN, Neal DE,. The molecular pathology of urological malignancies. J Pathol 1997; 183: 380-387.
32. DerSimonian R, Laird N,. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-188.
33. Durrleman S, Simon R,. Flexible regression-models with cubic-splines. Stat Med 1989; 8: 551-561.
34. Cordon-Cardo C,. Molecular alterations associated with bladder cancer initiation and progression. Scand J Urol Nephrol Suppl 2008: 154-165.
35. Jiang X, Castelao JE, Yuan JM, et al. Cigarette smoking and subtypes of bladder cancer. Int J Cancer 2012; 130: 896-901.
36. Brooks DR, Geller AC, Chang J, et al. Occupation, smoking, and the risk of high-grade invasive bladder cancer in Missouri. Am J Indus Med 1992; 21: 699-713.
37. Landman J, Droller MJ,. Risk factors in clonal development from superficial to invasive bladder cancer. Cancer Surv 1998; 31: 5-15.
38. Kadlubar FF, Miller JA, Miller EC,. Hepatic microsomal N-glucuronidation and nucleic acid binding of N-hydroxy arylamines in relation to urinary bladder carcinogenesis. Cancer Res 1977; 37: 805-814.
39. Alguacil J, Kogevinas M, Silverman DT, et al. Urinary pH, cigarette smoking and bladder cancer risk. Carcinogenesis 2011; 32: 843-847.
40. Silverman DT, Alguacil J, Rothman N, et al. Does increased urination frequency protect against bladder cancer? Int J Cancer 2008; 123: 1644-1648.
41. Willett W,. Chapter 13. Issues in analysis and presentation of dietary dataC nutritional epidemiologyed. New York: Oxford University Press, Inc., 1998.
42. Brennan P, Bogillot O, Cordier S, et al. Cigarette smoking and bladder cancer in men: a pooled analysis of 11 case-control studies. Int J Cancer 2000; 86: 289-294.
43. Ibrahim ASKH,. Urinary bladder cancer. In:, Freedman LSEB, Ries LAG, Young JL, eds. Cancer Incidence in Four Member Countries (Cyprus, Egypt, Israel, and Jordan) of the Middle East Cancer Consortium (MECC) compared with US SEERed. Bethesda, MD: NIH Pub., 2006.